Anticorps Polyclonal de lapin anti-BRAF

BRAF Polyclonal Antibody for WB, IHC, IF/ICC, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, souris et plus (1)

Applications

WB, IHC, IF/ICC, ELISA

Conjugaison

Non conjugué

Publications(17)

Avis (1)

N° de cat : 20899-1-AP

Synonymes

B RAF1, BRAF1, EC:2.7.11.1, p94, Proto-oncogene B-Raf

---

Galerie de données de validation

• 

  WB analysis using 20899-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 20899-1-AP (BRAF antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours.

• 

  WB analysis using 20899-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 20899-1-AP (BRAF antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours.

• 

  IHC staining of human lymphoma using 20899-1-AP

  Immunohistochemical analysis of paraffin-embedded human lymphoma tissue slide using 20899-1-AP (BRAF antibody) at dilution of 1:500 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human lymphoma using 20899-1-AP

  Immunohistochemical analysis of paraffin-embedded human lymphoma tissue slide using 20899-1-AP (BRAF antibody) at dilution of 1:500 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human malignant melanoma using 20899-1-AP

  Immunohistochemical analysis of paraffin-embedded human malignant melanoma tissue slide using 20899-1-AP (BRAF Antibody) at dilution of 1:200 (under 10x lens).

• 

  IHC staining of human malignant melanoma using 20899-1-AP

  Immunohistochemical analysis of paraffin-embedded human malignant melanoma tissue slide using 20899-1-AP (BRAF Antibody) at dilution of 1:200 (under 40x lens).

• 

  IHC staining of human thyroid cancer using 20899-1-AP

  Immunohistochemical analysis of paraffin-embedded human thyroid cancer tissue slide using 20899-1-AP (BRAF antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human thyroid cancer using 20899-1-AP

  Immunohistochemical analysis of paraffin-embedded human thyroid cancer tissue slide using 20899-1-AP (BRAF antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human testis using 20899-1-AP

  Immunohistochemical analysis of paraffin-embedded human testis tissue slide using 20899-1-AP (BRAF Antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human testis using 20899-1-AP

  Immunohistochemical analysis of paraffin-embedded human testis tissue slide using 20899-1-AP (BRAF Antibody) at dilution of 1:50 (under 40x lens).

• 

  IF Staining of NIH/3T3 using 20899-1-AP

  Immunofluorescent analysis of (-20°C Ethanol) fixed NIH/3T3 cells using BRAF antibody (20899-1-AP) at dilution of 1:400 and CoraLite®488-Conjugated Goat Anti-Rabbit IgG(H+L) (SA00013-2).

• 

  IF Staining of HeLa using 20899-1-AP

  Immunofluorescent analysis of (-20°C Ethanol) fixed HeLa cells using BRAF antibody (20899-1-AP) at dilution of 1:200 and CoraLite®488-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L).

---

Applications testées

• Résultats positifs en WB: cellules HT-29, cellules HEK-293, cellules HeLa, cellules Jurkat, cellules K-562, cellules NIH/3T3
• Résultats positifs en IHC: tissu de lymphome humain, tissu de cancer de la thyroïde humain, tissu de mélanome malin humain, tissu testiculaire humain; il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
• Résultats positifs en IF/ICC: cellules NIH/3T3, cellules HeLa

Dilution recommandée

• Western Blot (WB): WB : 1:1000-1:4000
• Immunohistochimie (IHC): IHC : 1:250-1:1000
• Immunofluorescence (IF)/ICC: IF/ICC : 1:200-1:800

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• WB: See 15 publications below
• IHC: See 1 publications below
• IF: See 1 publications below

Informations sur le produit

20899-1-AP cible BRAF dans les applications de WB, IHC, IF/ICC, ELISA et montre une réactivité avec des échantillons Humain, souris

• Réactivité: Humain, souris
• Réactivité citée: Humain, poulet, souris
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: BRAF Protéine recombinante Ag15014
• Nom complet: v-raf murine sarcoma viral oncogene homolog B1
• Masse moléculaire calculée: 766 aa, 84 kDa
• Poids moléculaire observé: 65-70 kDa
• Numéro d’acquisition GenBank: BC101757
• Symbole du gène: BRAF
• Identification du gène (NCBI): 673
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS with 0.02% sodium azide and 50% glycerol
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

B-Raf proto-oncogene serine/threonine kinase(BRAF), is a protein belonging to the raf/mil family of serine/threonine protein kinases. BRAF plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. BRAF is associated with cardiofaciocutaneous syndrome, a disease characterized by heart defects, mental retardation and a distinctive facial appearance. BRAF is also associated with various cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma, non-small cell lung carcinoma, and adenocarcinoma of lung. BRAF plays a role in the PD-1/PDL-1 pathway. In some cancers, BRAF is activated by rearrangements that fuse its kinase domain to 5' partner genes and then has different molecular weights (PMID: 23890088). BRAF has several isoforms, the calculated molecular weight of BRAF is 84 kDa, but the observed molecular weight is about 65 kDa(isoform).

Publications

Species	Application	Title
mouse	WB	Acta Pharmacol Sin; 1-Indanone retards cyst development in ADPKD mouse model by stabilizing tubulin and down-regulating anterograde transport of cilia; Authors - Xiao-Wei Li
human	WB	J Eur Acad Dermatol Venereol; Differentially expressed proteins identified by TMT proteomics analysis in children with verrucous epidermal naevi.; Authors - T Yuan
human	WB	Biochim Biophys Acta Mol Cell Res; IL-17 promotes melanoma through TRAF2 as a scaffold protein recruiting PIAS2 and ELAVL1 to induce EPHA5; Authors - Junfeng Du
human	WB	Front Immunol; Immune Dysfunction Mediated by the ceRNA Regulatory Network in Human Placenta Tissue of Intrahepatic Cholestasis Pregnancy.; Authors - Yuya Wang
human	WB	Life Sci; Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer.; Authors - Chong Yuan
chicken	WB	Gene; WT1 suppresses follicle-stimulating hormone-induced progesterone secretion by regulating ERK1/2 pathway in chicken preovulatory granulosa cells.; Authors - Shuixin Tang

Avis

The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.

---

FH

Reyes (Verified Customer) (09-24-2025)

BRAF (in green) seemed to work weakly but specifically in human brain cortical samples of TSC marking some NeuN-positive neurons (in red)

• Applications: Immunofluorescence
• Primary Antibody Dilution: 1:100
• Cell Tissue Type: Human Brain Cortex

BRAF Antibody Immunofluorescence validation (1:100 dilution) in Human Brain Cortex (Cat no:20899-1-AP)

{{ptg:RelatedPrimaryAntibodies}}